We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

POC Assay Could Diagnose Acute Coronary Syndrome in 3-5 Minutes

By HospiMedica International staff writers
Posted on 19 Dec 2022
Print article
Image: TruHeart technology aims to prevent heart disease mortality by early point-of-care diagnosis (Photo courtesy of Neuome Peptides)
Image: TruHeart technology aims to prevent heart disease mortality by early point-of-care diagnosis (Photo courtesy of Neuome Peptides)

32% of all global deaths are due to cardiovascular disease (CVD), with 85% of the deaths attributed to heart attack or stroke. This disease state may go undiagnosed due to confusion of symptoms with other medical issues or lack of proper medical attention. Even when discovered, a CVD incident can be too far gone before a heart attack or stroke occurs. There is a need for a preliminary medical test that can be easily taken in any environment that can alert a patient and their medical team to the potential of a cardiac event. Now, a cardiac-specific quantitative test using a finger-prick sample could offer results in 3-5 minutes at the point of care and help in identifying cardiovascular problems anywhere.

Neuome Peptides (Singapore) is in the advanced stages of developing TruHeart, a point of care biomarker assay to diagnose Acute Coronary Syndrome that can give quantifiable results within 3-5 minutes, using a finger-prick sample to test for the crucial biomarkers, Troponins I and T, and Myoglobin (eventually expanding to D-Dimer and Brain Natriuretic Peptide). It is in the advanced stages of R&D and progressing to global clinical trials. It will be submitted for FDA approval and then introduced to the market upon approval. The company’s technology for detecting these biomarkers uses a unique ability to bind at more than one binding site when conjugated with gold nanoparticles.

Such highly sensitive assay platforms can enable early detection of biomarkers even at very low concentration, without needing a laboratory. The test can be used at home, in ambulances, or in emergency rooms, where the results can be acted upon immediately. The product could be a game-changer, allowing patients to affordably screen for this potentially deadly condition conveniently early, in their own home, achieving quantifiable results without needing a laboratory. In comparison to industry standards, it will be uniquely affordable; its peptide-coated cartridges will cost only ~USD 2, while the quantitative electronic reader will cost ~USD 80. This is in contrast to existing point-of-care devices also giving quantitative results for cardiac biomarkers, but at device costs of up to USD 4,500, with cartridges ranging from USD 18-37.

Related Links:
Neuome Peptides

Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Portable Manual Defibrillator
Portable Medical Air Compressor
Eye Protector

Print article



view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: The new biomaterial heals tissues from the inside out (Photo courtesy of UC San Diego)

Groundbreaking Biomaterial Injected Intravenously Repairs Cells and Tissue Damaged by Heart Attack and TBI

Following a heart attack, there is development of scar tissue, which affects muscle function and can result in congestive heart failure. However, there is still no established treatment available for repairing... Read more

Surgical Techniques

view channel
Image: The neuro-chip with soft implantable electrodes could manage brain disorders (Photo courtesy of EPFL)

Implantable Neuro-Chip Uses Machine Learning Algorithm to Detect and Treat Neurological Disorders

Using a combination of low-power chip design, machine learning algorithms, and soft implantable electrodes, researchers have produced a neural interface that can identify and suppress symptoms of different... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more


view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.